{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:46:22Z","timestamp":1776897982679,"version":"3.51.2"},"reference-count":30,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,9,17]]},"abstract":"<jats:p>\n            <jats:named-content content-type=\"genus-species\">Neisseria gonorrhoeae<\/jats:named-content>\n            is the predominant cause of male urethral discharge in South Africa, and escalating prevalence of gonococcal antimicrobial resistance (AMR) is a major health concern both in-country and globally. We analyzed the demographic, behavioral, and clinical characteristics of 685 men presenting with gonococcal urethral discharge to sentinel surveillance clinics over a 3-year period (2017 to 2019) to determine the burden of factors that are known to be associated with\n            <jats:named-content content-type=\"genus-species\">N. gonorrhoeae<\/jats:named-content>\n            AMR to first-line therapy (defined as group 1 isolates exhibiting resistance or reduced susceptibility to extended-spectrum cephalosporins or azithromycin).\n          <\/jats:p>","DOI":"10.1128\/aac.00389-21","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T20:34:55Z","timestamp":1627936495000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["Demographic and Behavioral Risk Factors Associated with Reduced Susceptibility of Neisseria gonorrhoeae to First-Line Antimicrobials in South African Men with Gonococcal Urethral Discharge"],"prefix":"10.1128","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1314-7418","authenticated-orcid":true,"given":"Ranmini S.","family":"Kularatne","sequence":"first","affiliation":[{"name":"Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa"},{"name":"Department of Clinical Microbiology and Infectious Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tendesayi","family":"Kufa","sequence":"additional","affiliation":[{"name":"Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa"},{"name":"School of Public Health, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindy","family":"Gumede","sequence":"additional","affiliation":[{"name":"Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dumisile V.","family":"Maseko","sequence":"additional","affiliation":[{"name":"Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa"},{"name":"Westmead Clinical School and Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Westmead, New South Wales, Australia"},{"name":"Western Sydney Sexual Health Centre, Western Sydney Local Health District, Parramatta, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","volume-title":"Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. 2017. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_3_2","first-page":"114","article-title":"Aetiological surveillance of sexually transmitted infection syndromes at sentinel sites: GERMS-SA 2014\u20132016","volume":"15","author":"Kularatne R","year":"2017","unstructured":"Kularatne R. 2017. Aetiological surveillance of sexually transmitted infection syndromes at sentinel sites: GERMS-SA 2014\u20132016. NICD Bull 15:114\u2013122. https:\/\/www.nicd.ac.za\/wp-content\/uploads\/2017\/03\/NICD-Bulletin-Vol_15_Iss3-November_2017.pdf.","journal-title":"NICD Bull"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181d877b7"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics7030058"},{"key":"e_1_3_2_6_2","volume-title":"Global antimicrobial resistance and use surveillance system (GLASS) report 2021","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. 2021. Global antimicrobial resistance and use surveillance system (GLASS) report 2021. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_7_2","volume-title":"Standard treatment guideline and essential medicine list","author":"Republic of South Africa National Department of Health","year":"2018","unstructured":"Republic of South Africa National Department of Health. 2018. Standard treatment guideline and essential medicine list. 6th ed. Republic of South Africa National Department of Health, Pretoria, South Africa. https:\/\/extranet.who.int\/ncdccs\/Data\/ZAF_D1aia_STG%20and%20EML%20PHC%202018.pdf.","edition":"6"},{"key":"e_1_3_2_8_2","volume-title":"National Health Act, 2003 (act no 61 of 2003): regulations relating to the surveillance and the control of notifiable medical conditions","author":"Republic of South Africa National Department of Health","year":"2017","unstructured":"Republic of South Africa National Department of Health. 2017. National Health Act, 2003 (act no 61 of 2003): regulations relating to the surveillance and the control of notifiable medical conditions. Republic of South Africa National Department of Health, Pretoria, South Africa. https:\/\/www.gov.za\/sites\/default\/files\/gcis_document\/201706\/40945gon604.pdf."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000185"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01221-19"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2016.11.012"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2016-052583"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.2807\/ese.14.37.19330-en"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt034"},{"key":"e_1_3_2_15_2","volume-title":"UNAIDS data 2020","author":"UNAIDS","year":"2020","unstructured":"UNAIDS. 2020. UNAIDS data 2020. 2nd ed. UNAIDS, Geneva, Switzerland.","edition":"2"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2007.029611"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1512757"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800323"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.10.1900147"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.47.1800617"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.36.1900528"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2402.171756"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2404.171873"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30340-2"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2507.190172"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2509.190407"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ731"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02069-17"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2014-051731"},{"key":"e_1_3_2_30_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2021. Breakpoint tables for interpretation of MICs and zone diameters version 11 2021. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_11.0_Breakpoint_Tables.pdf."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw288"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00389-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00389-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:29:52Z","timestamp":1645486192000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00389-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,9,17]]}},"alternative-id":["10.1128\/AAC.00389-21"],"URL":"https:\/\/doi.org\/10.1128\/aac.00389-21","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"assertion":[{"value":"2021-02-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00389-21"}}